Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus

被引：34
|
作者：
McCance, D. R. [1 ]
Damm, P. [2 ]
Mathiesen, E. R. [3 ]
Hod, M. [4 ]
Kaaja, R. [5 ]
Dunne, F.
Jensen, L. E. [6 ]
Mersebach, H. [6 ]
机构：
[1] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland
[2] Univ Copenhagen Hosp, Dept Obstet, Rigshosp, DK-2100 Copenhagen, Denmark
[3] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark
[4] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Helen Schneider Hosp Women,Perinatal Div, IL-49100 Petah Tiqwa, Israel
[5] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[6] Novo Nordisk, Global Dev, Bagsvaerd, Denmark
来源：
DIABETOLOGIA | 2008年 / 51卷 / 11期
关键词：
human insulin; insulin antibody; insulin aspart; pregnancy; type; 1; diabetes;
D O I：
10.1007/s00125-008-1120-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2141 / 2143
页数：3
相关论文
共 50 条
  • [1] Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus
    D. R. McCance
    P. Damm
    E. R. Mathiesen
    M. Hod
    R. Kaaja
    F. Dunne
    L. E. Jensen
    H. Mersebach
    Diabetologia, 2008, 51 : 2141 - 2143
  • [2] Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus
    Velasquez-Mieyer, Pedro A.
    Neira, Claudia P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2377 - 2382
  • [3] A Pregnant Patient with Brittle Type 1 Diabetes Successfully Managed by CSII Therapy with Insulin Aspart
    Higuchi, Chigusa
    Tone, Atsuhito
    Iseda, Izumi
    Tsukamoto, Keiko
    Katayama, Akihiro
    Wada, Jun
    Shikata, Kenichi
    Hida, Kazuyuki
    JOURNAL OF DIABETES & METABOLISM, 2010, 1 (01)
  • [4] Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus
    Lason, Izabela
    Cyganek, Katarzyna
    Witek, Przemyslaw
    Matejko, Bartlomiej
    Malecki, Maciej T.
    Skupien, Jan
    GINEKOLOGIA POLSKA, 2021, 92 (10) : 675 - 681
  • [5] Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK
    Lloyd, A.
    Townsend, C.
    Munro, V.
    Twena, N.
    Nielsen, S.
    Holman, A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 599 - 605
  • [6] Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart-A secondary analysis of the CopenFast trial
    Soholm, Julie C.
    Norgaard, Sidse K.
    Norgaard, Kirsten
    Clausen, Tine D.
    Damm, Peter
    Mathiesen, Elisabeth R.
    Ringholm, Lene
    DIABETIC MEDICINE, 2025, 42 (01)
  • [7] Safety and efficacy of insulin aspart and soluble human insulin in Type 2 diabetes mellitus
    Cucinotta, D.
    Caputo, S.
    Mannucci, E.
    Nicolucci, A.
    Pellegrini, F.
    Perriello, G.
    Sbraccia, P.
    MINERVA ENDOCRINOLOGICA, 2012, 37 (04) : 357 - 366
  • [8] Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects
    Hod, Moshe
    Damm, Peter
    Kaaja, Risto
    Visser, Gerard H. A.
    Dunne, Fidelma
    Demidova, Irina
    Hansen, Anne-Sofie Pade
    Mersebach, Henriette
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (02) : 186.e1 - 186.e7
  • [9] Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus
    Brunner, GA
    Hirschberger, S
    Sendlhofer, G
    Wutte, A
    Ellmerer, M
    Balent, B
    Schaupp, L
    Krejs, GJ
    Pieber, TR
    DIABETIC MEDICINE, 2000, 17 (05) : 371 - 375
  • [10] A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes
    Meneilly, G. S.
    DIABETES OBESITY & METABOLISM, 2007, 9 (05) : 754 - 755
12345